ask="5.00"
ask_size="1000"
average_daily_volume="1433950"
bid="4.79"
bid_size="6300"
book_value="0.21"
change="-0.05"
change_from_200_day_moving_average="-0.46"
change_from_50_day_moving_average="-0.52"
change_from_52_week_high="-3.01"
change_From_52_week_low="0.80"
change_in_percent="-1.03%"
close="4.79"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.56"
ebitda="-113.37M"
eps_estimate_current_year="-0.68"
eps_estimate_next_quarter="-0.20"
eps_estimate_next_year="-0.15"
ex_dividend_date="N/A"
float_shares="71286000"
high="4.98"
high_52_weeks="7.80"
last_trade_date="3/2/2017"
last_trade_price="4.79"
last_trade_size="42685"
last_trade_time="4:00pm"
low="4.73"
low_52_weeks="3.99"
market_capitalization="507.55M"
moving_average_200_day="5.25"
moving_average_50_day="5.31"
name="Keryx Biopharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.07"
open="4.85"
pe_ratio="N/A"
peg_ratio="-0.06"
percent_change_from_200_day_moving_average="-8.76%"
percent_change_from_50_day_moving_average="-9.80%"
percent_change_from_52_week_high="-38.59%"
percent_change_from_52_week_low="+20.05%"
previous_close="4.84"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="23.27"
price_per_sales="18.16"
revenue="28.23M"
shares_outstanding="105960000"
short_ratio="12.76"
stock_exchange="NCM"
symbol="KERX"
volume="1636571"
weeks_range_52="3.99 - 7.80"
